Home
>
US Stocks
>
Akouos Inc
Akouos Inc
AKUS

Akouos Inc

$9.799.1%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
9.76
Today Low/High
9.66 / 10.08
52 Week Low/High
$10.5 / $30.67
Market Cap
$372.39M

Company Details

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy.
Organisation
Akouos Inc
Employees
69
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Akouos Inc share price today

Can Indians buy Akouos Inc shares?

How can I buy Akouos Inc shares from India?

Can Fractional shares of Akouos Inc be purchased?

What are the documents required to start investing in Akouos Inc stocks?

We are a SEBI registered investement advisor